JNCE - Jounce Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $4.65. This is a potential upside of $4.65 (0%) from yesterday's end of day stock price of $0.

Jounce Therapeutics's activity chart (see below) currently has 34 price targets and 28 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15.63% with an average time for these price targets to be met of 262 days.

Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 28-Mar-2023.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$2

$0.12 (6.38%)

$7

2 years 2 months 20 days ago
(28-Mar-2023)

0/4 (0%)

$0.16 (8.70%)

Hold

$3

2 years 3 months 25 days ago
(23-Feb-2023)

2/8 (25%)

$1.83 (156.41%)

622

Buy

$5

$3.12 (165.96%)

$9

2 years 5 months 14 days ago
(03-Jan-2023)

0/4 (0%)

$3.91 (358.72%)

Buy

$11

$9.12 (485.11%)

$15

2 years 10 months 12 days ago
(05-Aug-2022)

0/2 (0%)

$6.84 (164.42%)

Buy

$15

$13.12 (697.87%)

$15

3 years 1 months 5 days ago
(12-May-2022)

0/4 (0%)

$10.75 (252.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JNCE (Jounce Therapeutics) average time for price targets to be met?

On average it took 262 days on average for the stock forecasts to be realized with a an average price target met ratio 15.63

Which analyst has the current highest performing score on JNCE (Jounce Therapeutics) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the current lower performing score on JNCE (Jounce Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on JNCE (Jounce Therapeutics)?

Steven Seedhouse works at RAYMOND JAMES and has 7 price targets and 5 ratings on JNCE

Which analyst is the currently most bullish on JNCE (Jounce Therapeutics)?

Zegbeh Jallah with highest potential upside - $13.12

Which analyst is the currently most reserved on JNCE (Jounce Therapeutics)?

Steven Seedhouse with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?